Diabetes

BROUGHT TO YOU BY

Recent

Illumina Set to Acquire Grail for $8B

Sep 21, 2020

10 FDA Cleared or Approved Wearable Devices that Redefined Healthcare

Sep 20, 2020

Medtech in a Minute: Big Deal Rumor, Apple's Blood Oxygen Tracker, and More

Sep 18, 2020

Saint-Gobain Life Sciences Acquires MS Techniques and Transluminal and More Supplier News

Sep 18, 2020

News
Products
Whitepapers

Improve Scientific Software with These UX Design Best Practices

Sep 17, 2020

Medtech Unfiltered: Who Is Elizabeth Holmes?

Sep 17, 2020

Does Illumina Want Grail Back?

Sep 17, 2020

Has Takeda Finally Found a Home for TachoSil Patch?

Sep 16, 2020

EU Medical Device Regulation: What Does Postponement Mean for Medtech?

Listen on-demand to our series of free webinars examining the postponement of the EU Medical Device Regulation

Highlights

Could MiniMed 770G’s Approval Boost Medtronic’s Position in Diabetes?

Sep 01, 2020

The MiniMed 770G is significant because it has smartphone connectivity and will be available to patients as young as 2-years-old.

Brace Yourself for a More Competitive Medtronic

Aug 26, 2020

Medtronic CEO Geoff Martha says the company is becoming a more nimble and a more competitive organization.

Medtronic Set to Acquire Companion Medical, but Is This Just the Beginning?

Aug 16, 2020

During a May earnings call, Medtronic executives expressed an appetite for M&A and pointed out it is a good time...

Receive Marketing Updates

We may wish to contact you regarding future events and products including MD+DI Digital, please uncheck this box if you do not wish to receive these updates.

I would like to hear about related events and products, including future editions of MD+DI Digital. *

Receive Third Party Communications

MD+DI Digital's carefully selected third party partners may wish to contact you. Please uncheck this box if you do not wish to receive these communications.

I would like to hear from MD+DI Digital's carefully selected third parties. *

You may withdraw your consent to receive any of our communications at any time. You understand that your information will be used in accordance with the Privacy Policy.

Agree to Terms

Enter your email above to receive messages about offerings by Informa, its brands, affiliates and/or third-party partners, consistent with Informa's Privacy Statement.

List

Leave this field blank

Medtech in a Minute: A Liquid Biopsy Player Thrives, Broader COVID-19 Testing, and More

Aug 03, 2020

Pressed for time? Here's the medtech news you need most, in one minute or less.

Dexcom No Longer Sharing Timeline for G7 Trial

Jul 30, 2020

Dexcom CEO says the company has made progress on "several fronts" regarding the G7 pivotal trials, however the company is no longer disclosing timeline specifics.

Tandem Sure Has Been Busy Lately. What’s Up with That?

Jul 10, 2020

MD+DI Managing Editor Omar Ford digs into the recent activity and explains what it means for Tandem and what it could mean for companies during the COVID-19 pandemic.

Tandem Strikes up Patent Cross-License Agreement with Medtronic

Jul 09, 2020

This is the second-high profile collaboration San Diego, CA-based Tandem Diabetes Care has announced in recent weeks. Tandem also struck a deal that would call for its insulin delivery systems to be integrated into Abbott Laboratories’ Freestyle...

Tandem and Abbott’s Big Play in Diabetes Management

Jun 29, 2020

The two companies are in an agreement that would call for Tandem’s insulin delivery systems to be integrated with Abbott’s...

Medtech in a Minute: Texas Halts Elective Surgery, a Sweet Deal, and More

Jun 26, 2020

Pressed for time? Here's the medtech news you need most, in one minute or less.

Tandem Lands a ‘Sweet’ Deal as Medtech M&A Picks Up

Jun 24, 2020

The San Diego, CA-based company is acquiring Sugarmate, a developer of a mobile app for people with diabetes who use insulin...

Dexcom Teams Up With Kore for Remote Patient Monitoring Solution

Jun 17, 2020

San Diego, CA-based Dexcom’s solution allows for continuous glucose monitoring by measuring glucose levels automatically every five minutes and transmitting the data to a handheld mobile device, which can be accessed from a safe distance.

It’s Finally Here … FDA Clears Abbott’s Freestyle Libre 2 iCGM

Jun 15, 2020

Abbott’s Freestyle Libre 2 iCGM can be used in adults and children over age 4 for a 14-day period. The Abbott Park, IL-based company also released promising data at the American Diabetes Association 80th Scientific Sessions this past weekend.

Medtech in a Minute: Cue Health Is on a Roll, Predicting Future Glucose Levels, and More

Jun 14, 2020

Pressed for time? Here's the medtech news you need most, in one minute or less.

Load More
1
2
next
last

About
Advertise
Subscribe
Design News
PlasticsToday
Packaging Digest
Powder & Bulk Solids

MD&M West
MD&M East
MD&M Minneapolis
BIOMEDevice Boston
BIOMEDevice San Jose
Sitemap

Accessibility
Privacy Policy
Cookie Policy
Terms of Use
Visitor Terms and Conditions